切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2023, Vol. 17 ›› Issue (04) : 361 -366. doi: 10.3877/cma.j.issn.1674-3253.2023.04.010

临床研究

术前复查尿培养在预测微通道经皮肾镜取石术相关感染并发症中的作用
窦上文, 邓欢, 刘邦锋, 岳高远志, 朱华财, 刘永达()   
  1. 510500 广州,广州医科大学附属第一医院泌尿外科
    518000 深圳,宝安区石岩人民医院泌尿外科
  • 收稿日期:2023-05-03 出版日期:2023-08-01
  • 通信作者: 刘永达
  • 基金资助:
    广东省基础与应用基础研究基金(2020A1515011461)

Role of preoperative urine culture re-examination in the prediction of infectious complications related to mini-percutaneous nephrolithotomy

Shangwen Dou, Huan Deng, Bangfeng Liu, Gaoyuanzhi Yue, Huacai Zhu, Yongda Liu()   

  1. Department of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510500, China
    Department of Urology, Shenzhen Shiyan People's Hospital, Shenzhen 518000, China.
  • Received:2023-05-03 Published:2023-08-01
  • Corresponding author: Yongda Liu
引用本文:

窦上文, 邓欢, 刘邦锋, 岳高远志, 朱华财, 刘永达. 术前复查尿培养在预测微通道经皮肾镜取石术相关感染并发症中的作用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 361-366.

Shangwen Dou, Huan Deng, Bangfeng Liu, Gaoyuanzhi Yue, Huacai Zhu, Yongda Liu. Role of preoperative urine culture re-examination in the prediction of infectious complications related to mini-percutaneous nephrolithotomy[J/OL]. Chinese Journal of Endourology(Electronic Edition), 2023, 17(04): 361-366.

目的

探讨术前尿培养阳性肾结石患者经过敏感抗生素治疗后,复查尿培养对于预测微通道经皮肾镜碎石取石术(PCNL)相关感染并发症的作用。

方法

前瞻性、连续性收集在广州医科大学附属第一医院泌尿外科三区术前尿培养阳性并接受微通道PCNL治疗患者的临床资料,根据术前尿培养的药物敏感试验结果,对患者行敏感抗生素治疗,分别在第3、7天复查尿培养。患者经过敏感抗生素治疗7 d后接受微通道PCNL治疗,分析第3、7 d的尿培养结果与微通道PCNL术后相关感染并发症的相关性。

结果

2021年3月至2023年4月共收集100例患者临床资料,单因素分析的结果显示年龄、性别、糖尿病史、术前静脉血白细胞、手术时间≥90 min等与微通道PCNL术后相关感染并发症无明显相关性(P>0.05)。第3天复查尿培养,阴性95例,术后出现发热20例,其中脓毒症3例;尿培养阳性5例,术后发热1例,其中脓毒症1例。第7天复查尿培养,阴性95例,术后出现发热19例,其中脓毒血症4例;尿培养阳性5例,术后出现发热2例,无脓毒血症。单因素分析结果显示第3、7天尿培养结果与微通道PCNL相关感染并发症无明显相关性(P>0.05)。

结论

术前尿培养阳性肾结石患者经过敏感抗生素治疗,复查尿培养对微通道PCNL术后相关感染性并发症的预测价值有限。对于术前尿培养阳性患者,建议使用敏感抗生素治疗7 d后再行微通道PCNL。

Objective

To explore the predictive value of urine culture re-examination in identifying infectious complications associated with mini-PCNL in patients with preoperative positive urine culture who were treated with sensitive antibiotics.

Methods

Prospective and consecutive clinical data were collected from patients whose preoperative urine culture was positive and who underwent PCNL at the Department of Urology, the First Affiliated Hospital of Guangzhou Medical University. If patients’ preoperative urine cultures were positive, they would be treated with appropriate antibiotics in accordance with the culture-antibiogram test results, and urine cultures were repeated on day 3 and day 7. Patients would undergo mini-PCNL after the treatment of sensitive antibiotics for 7 days, and the correlation between the results of urine culture on day 3 and day 7 and infectious complications related to mini-PCNL after surgery was analyzed.

Results

From March 2021 to April 2023, a total of 100 patients' clinical data were collected. Univariate analysis showed that the factors including age, gender, diabetes history, preoperative venous leukocyte, and operation time were not significantly correlated with infection complications after mini-PCNL surgery (P>0.05). Reexamination of urine culture on the third day showed negative results in 95 cases, postoperative fever in 20 cases, including 3 cases of sepsis, positive urine culture in 5 cases, postoperative fever in 1 case, including sepsis in 1 case. Reexamination of urine culture on the 7th day showed negative results in 95 cases, 19 cases developed fever after operation, including 4 cases of sepsis. Urine culture was positive in 5 cases, and postoperative fever occurred in 2 cases without sepsis. Univariate analysis showed the results of urine culture on day 3 and 7 were not significantly correlated with infectious complications after mini-PCNL surgery (P>0.05).

Conclusions

The value of re-examination of urine culture in predicting postoperative infectious complications related to mini-PCNL is limited in patients with positive urine culture treated with sensitive antibiotics before surgery. For patients with positive urine culture before surgery, it is recommended to perform mini-PCNL after 7 days of treatment with sensitive antibiotics.

表1 微通道PCNL术后发热组和无发热组一般资料的比较
表2 微通道PCNL术后尿源性脓毒血症患者与非脓毒症患者资料的比较
表3 100例行微通道PCNL的患者尿液细菌培养分布情况
表4 第3、7天尿培养结果与微通道PCNL术后发热的相关性(例)
表5 第3、7天尿培养结果与微通道PCNL术后尿源性脓毒血症的相关性(例)
表6 结石培养结果与微通道PCNL术后发热的相关性(例)
表7 结石培养结果与微通道PCNL术后尿源性脓毒血症的相关性(例)
[1]
Zeng G, Zhong W, Mazzon G, et al. International Alliance of Urolithiasis (IAU) Guideline on percutaneous nephrolithotomy[J]. Minerva Urol Nephrol, 2022, 74(6): 653-668.
[2]
Chugh S, Pietropaolo A, Montanari E, et al. Predictors of urinary infections and urosepsis after ureteroscopy for stone disease: a systematic review from EAU section of urolithiasis (EULIS)[J]. Curr Urol Rep, 2020, 21(4): 16.
[3]
Margel D, Ehrlich Y, Brown N, et al. Clinical implication of routine stone culture in percutaneous nephrolithotomy-a prospective study[J]. Urol Int, 2006, 67(1): 26-29.
[4]
Lojanapiwat B, Kitirattrakarn P. Role of preoperative and intraoperative factors in mediating infection complication following percutaneous nephrolithotomy[J]. Urol Int, 2011, 86(4): 448-452.
[5]
Zeng T, Chen D, Wu W, et al. Optimal perioperative antibiotic strategy for kidney stone patients treated with percutaneous nephrolithotomy[J]. It J Infect Dis, 2020, 97:162-166.
[6]
Mariappan P, Smith G, Bariol SV, et al. Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy:a prospective clinical study[J]. J Urol, 2005, 173(5):1610-1614.
[7]
Sur RL, Krambeck AE, Large T, et al. A randomized controlled trial of pre-operative prophylactic antibiotics prior to percutaneous nephrolithotomy in moderate to high risk infectious risk population:a report from the EDGE consortium[J]. J Urol, 2021, 205(5): 1379-1386.
[8]
尹丹萍,陈庆莹,孙志东, 等.不同来源标本病原菌菌种的分布特点[J].解放军预防医学杂志, 2016, 34(1): 19-22..
[9]
Xu P, Zhang S, Zhang Y, et al. Preoperative antibiotic therapy exceeding 7 days can minimize infectious complications after percutaneous nephrolithotomy in patients with positive urine culture[J]. World J Urol, 2022, 40(1): 193-199.
[10]
谢京彤, 乔保平. 经皮肾镜碎石术后发热危险因素的分析[J]. 河南外科学杂志, 2019, 25(3): 22-23.
[11]
Armitage JN, Irving SO, Burgess NA, et al. Percutaneous nephrolithotomy in the United Kingdom: results of a prospective data registry[J]. Eur Urol, 2012, 61(6): 1188-1193.
[12]
Koras O, Bozkurt IH, Yonguc T, et al. Risk factors for postoperative infectious complications following percutaneous nephrolithotomy: a prospective clinical study[J]. Urolithiasis, 2015, 43(1): 55-60.
[13]
Michel MS, Trojan L, Rassweiler JJ. Complications in percutaneous nephrolithotomy[J]. Eur Urol, 2007, 51(4): 899-906.
[14]
Kreydin EI, Eisner BH. Risk factors for sepsis after percutaneous renal stone surgery[J]. Nat Rev Urol, 2013, 10(10): 598-605.
[15]
杨元强, 于佳, 徐建华, 等. 肾盂尿及结石细菌培养阳性的经皮肾镜碎石取石术残石与感染并发症相关性[J]. 中国临床研究, 2019, 32(9): 1242-1245.
[16]
邱宗文, 涂继伟, 解晓珍. 服用抗生素后对尿液细菌培养的影响及其对策[J]. 重庆医学, 2006, 35(18): 1660-1662.
[17]
肖辉, 房波, 秦刚, 等. 上尿路结石患者RIRS术前尿培养及术中结石细菌培养的病原菌分析[J]. 现代诊断与治疗, 2021, 32(20): 3199-3201.
[18]
王冠博, 刘蕾, 李海, 等. PCNL术中肾盂尿培养,结石培养与术前尿培养之间的关系及与术后脓毒血症的相关性研究[J]. 中国实验诊断学, 2021, 25(1): 72-74.
[19]
程希凤. 尿路感染患者中段尿液标本病原菌分布特征及耐药性分析[J]. 航空航天医学杂志, 2022, 33(12): 1445-1448.
[1] 庄燕, 戴林峰, 张海东, 陈秋华, 聂清芳. 脓毒症患者早期生存影响因素及Cox 风险预测模型构建[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(05): 372-378.
[2] 杨瑾, 刘雪克, 张媛媛, 金钧, 韦瑶. 肠道微生物来源石胆酸对脓毒症相关肝损伤的保护作用[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 265-274.
[3] 徐志刚, 曹涛, 何亭, 李博奥, 魏婧韬, 张栋梁, 官浩, 杨薛康. 采用抗生素骨水泥治疗糖尿病患者心脏术后胸骨骨髓炎的临床效果观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 498-502.
[4] 姜珊, 李湘燕, 田硕涵, 温冰, 何睿, 齐心. 采用优化抗感染治疗模式改善糖尿病足感染预后的临床观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(05): 398-403.
[5] 曹彬, 王强, 卢扬柏, 黄红星, 黄亚强, 龙永富, 钟睿, 李灿永, 罗刚. 单孔经皮肾镜和腹腔镜处理肾囊肿的术式对比研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 566-571.
[6] 石兵, 张智, 陈金海, 唐文. 基于电磁跟踪和手术导航系统的实时超声引导下两种经皮肾盏穿刺方法的应用[J/OL]. 中华腔镜泌��外科杂志(电子版), 2024, 18(06): 572-578.
[7] 苏博兴, 肖博, 李建兴. 2024年美国泌尿外科学会年会结石领域手术治疗相关热点研究及解读[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 303-308.
[8] 莫淇舟, 柳建军, 叶木石, 黄兴端, 李健维, 李思宁, 黄健, 苏劲. 二期原通道经皮肾镜联合输尿管软镜治疗经皮肾镜术后残石[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 380-385.
[9] 王石林, 叶继章, 丘向艳, 陈桂青, 邹晓敏. 慢性阻塞性肺疾病真菌感染风险早期预测分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 773-776.
[10] 王涛, 刘静, 高玉伟, 王兴华, 胡秀红, 崔红蕊, 徐保振, 杨洪娟. 抗生素耐药背景下中医药防治腹膜透析相关性腹膜炎研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 340-344.
[11] 成人脓毒症患者β-内酰胺类抗生素延长输注专家共识编写组. 成人脓毒症患者β-内酰胺类抗生素延长输注专家共识[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 313-324.
[12] 陈曦, 吴宗盛, 郑明珠, 邱海波. 胸腺萎缩在脓毒症免疫紊乱中的研究进展[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 379-383.
[13] 杨翔, 郭兰骐, 谢剑锋, 邱海波. 转录组学在脓毒症诊疗中的临床研究进展[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 384-388.
[14] 陈惠英, 邱敏珊, 邵汉权. 脓毒症诱发肠黏膜屏障功能损伤的风险因素模型构建与应用效果[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 448-452.
[15] 傅新露, 李之岳, 卢丹. 妊娠合并结肠癌穿孔致脓毒症休克一例并文献复习[J/OL]. 中华产科急救电子杂志, 2024, 13(04): 227-231.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?